Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

Documenti analoghi

• Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
  di: Mushood Ahmed, et al.
  Pubblicazione: (2024)
• Renal Protection at a Metabolic Cost: A Systematic Review and Meta‐Analysis of Perioperative Use of Sodium–Glucose Cotransporter 2 Inhibitors
  di: Elsayed Balbaa, et al.
  Pubblicazione: (2026)
• Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
  di: Nobutoshi Fushimi, et al.
  Pubblicazione: (2025)
• The Gastrointestinal Safety of Orforglipron, a GLP ‐1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta‐Analysis of Randomized Controlled Trials
  di: Ahmed W. Hageen, et al.
  Pubblicazione: (2026)
• Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT‐Q Study
  di: Mohammed Bashir, et al.
  Pubblicazione: (2024)